Final FDA 510(k) Substantial Equivalence Guidance

FDA issued a final guidance entitled “The 510(k) Program: Evaluating Substantial Equivalence in Premarket Notifications [510(k)]” dated July 28.2014. This guidance mentions software 18 times (including in the example). Software is considered one of the technological characteristics that could affect equivalence and examples include changes in the way software is used to analyze a patient’s anatomy or physiology.. The guidance also discusses the software information to be provided in the 510(k) related to demonstating substantial equivalence. The full guidance is at the link provided.

Schedule Discussion with John F. Murray, Jr.

John is currently providing telephone and face-to-face meetings to discuss:  Cybersecurity, Part 11, 483 Response, design controls expectations for software documentation, and other topics.

Leave a message and we will contact you to schedule:

Corporate Office

+1-781-721-2921
Partners located in the US (CA, FL, MA, MN, TN) and Italy.